The knowledge accumulated during the past decades on the chemistry and biology of bioorganic boron compounds laid the foundation for the emergence of a new area of study and application of boron compounds as lipophilic pharmacophores and modulators of biologically active molecules; for example, carborane-containing compounds inhibit HIV replication, show anticancer activity, modulate purinergic receptors, etc.
These and other recent findings clearly show that there is still great unexplored potential in medicinal applications of boron-containing compounds. This Medicinal Chemistry of Boron Compounds Conference will promote the development of new boron-containing drugs and materials for molecular medical diagnostics by bringing together renowned experts in the field of medicinal chemistry of boron compounds.
This content is blocked. Accept cookies to view the content.